8-K: DIH Holding Faces Nasdaq Delisting Threat

DIH Holding US, Inc. received a delisting notice from Nasdaq due to failing to meet market value and timely filing requirements, prompting a planned appeal.

Summary

• DIH Holding US, Inc. (DHAI) received a delisting notice from the Nasdaq Stock Market LLC on September 2, 2025.
• The delisting notice stems from the Company's failure to regain compliance with Nasdaq Listing Rule 5450(b)(2)(A), which requires a Market Value of Listed Securities (MVLS) of at least $50,000,000, by the September 1, 2025 deadline.
• Additionally, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to its failure to timely file its Form 10-Q for the period ended June 30, 2025, and its Form 10-K for the year ended March 31, 2025.
• The Company plans to timely request a hearing before the Nasdaq Hearing Panel to appeal the delisting determination and request an extended stay of any further action.
• The Nasdaq Hearing Panel has the authority to grant extensions of up to 180 days for MVLS compliance and 360 days for filing delinquency from the initial delist determination.
• There is no assurance that the Panel will grant the Company's request for continued listing or that the Company will be able to evidence compliance within any granted extension period.

Sentiment

Score: 2

Explanation: The filing indicates severe financial and regulatory distress, with the company facing delisting from Nasdaq due to non-compliance with market value and reporting requirements. While management plans to appeal, the outcome is uncertain, reflecting a highly negative situation.

Positives

• The Company plans to timely request a hearing before the Nasdaq Hearing Panel to appeal the delisting determination.
• The Company will request an extended stay of any further action pending the hearing, which will initially stay the suspension of common stock for 15 days.
• The Nasdaq Hearing Panel has the authority to grant extensions of up to 180 days for MVLS compliance and 360 days for filing delinquency, providing a potential pathway to regain compliance.

Negatives

• Received a delisting notice from Nasdaq on September 2, 2025, for non-compliance with listing rules.
• Failed to regain compliance with the Nasdaq MVLS Rule, requiring a market value of listed securities of at least $50,000,000, by the September 1, 2025 deadline.
• Failed to timely file its Form 10-Q for the period ended June 30, 2025.
• Remains delinquent in filing its Form 10-K for the year ended March 31, 2025.
• There is no assurance that the Nasdaq Hearing Panel will grant the Company's request for continued listing or an extension of time.
• There is no assurance that the Company will be able to evidence compliance within any period of time that may be granted by the Panel.

Risks

• Risk of delisting from the Nasdaq Stock Market, which could severely impact the liquidity and marketability of the Company's securities.
• Uncertainty regarding the Nasdaq Hearing Panel's decision to grant an extension for continued listing or the terms of any such extension.
• Inability to regain compliance with Nasdaq's Market Value of Listed Securities (MVLS) rule ($50,000,000 threshold) and timely filing requirements (Form 10-Q and 10-K).
• Potential for further decline in the Company's stock price and investor confidence if delisting occurs or compliance is not achieved.
• General economic, political, and business conditions could adversely affect the Company's ability to improve its financial standing and market valuation.
• Failure to achieve projected revenue, which could exacerbate financial challenges.
• Failure to realize the anticipated benefits of the recently-completed business combination.
• Difficulty accessing sources of additional debt or equity capital if needed to support operations or regain compliance.

Future Outlook

The Company plans to request a hearing before the Nasdaq Hearing Panel to appeal the delisting determination and seek an extension of time to regain compliance with both the MVLS Rule and the Reports Rule. While the Panel has the authority to grant extensions of up to 180 days for MVLS and 360 days for filing delinquencies, there is no assurance that such an extension will be granted or that the Company will successfully achieve compliance within any given timeframe.

Management Comments

• "The Company plans to timely request a hearing before the Panel, and this request will stay the suspension of the Company's Common Stock for a period of 15 days from the date of the request."
• "In connection with this request, the Company plans to also request an extended stay of any further action pending the hearing."
• "At the hearing, the Company will present its plan to evidence compliance with all applicable listing criteria, including the MVLS Rule and the Reports Rule, and request an extension of time."
• "The Company is considering all options available to it to regain compliance with the MVLS Rule and the Reports Rule; however, there can be no assurance that the Panel will grant the Company's request for continued listing or that the Company will be able to evidence compliance within the period of time that may be granted by the Panel."

Industry Context

DIH Holding US, Inc. operates in the global market for advanced robotic devices used in physical rehabilitation, aiming to improve the lives of individuals with disabilities. The company positions itself as a consolidator in a fragmented, manual-labor-driven industry. While the delisting notice is a company-specific regulatory issue, sustained non-compliance and potential delisting could hinder its ability to execute its consolidation strategy and compete effectively, especially against larger, more financially stable players in the medical device and rehabilitation technology sectors. The inability to maintain a Nasdaq listing could severely impact its access to capital and market visibility, which are crucial for growth and M&A activities in a competitive industry.

Stakeholder Impact

• Shareholders: Face significant risk of delisting, which could lead to reduced liquidity, lower share price, and potential transfer to over-the-counter markets, severely impacting investment value.
• Investors: Increased uncertainty and risk associated with the company's future listing status, financial stability, and ability to access capital markets.
• Employees: Potential for uncertainty regarding the company's long-term viability, job security, and operational stability due to financial and regulatory challenges.
• Customers/Suppliers: May experience concerns about the company's financial health and ability to fulfill obligations, potentially impacting business relationships and future contracts.

Next Steps

• Timely request a hearing before the Nasdaq Hearing Panel to appeal the delisting determination.
• Request an extended stay of any further action from Nasdaq pending the hearing.
• Present a comprehensive plan to evidence compliance with all applicable Nasdaq listing criteria, including the MVLS Rule and the Reports Rule, at the hearing.
• Seek an extension of time from the Nasdaq Hearing Panel to regain full compliance with listing requirements.
• Consider all available options to regain compliance with Nasdaq listing rules.

Key Dates

Recommendation

The company faces imminent delisting from Nasdaq due to severe non-compliance with both market value and critical financial reporting requirements. While an appeal is planned, there is no assurance of success or the ability to regain compliance within any granted timeframe. This situation indicates significant financial distress, severe regulatory risk, and a high degree of uncertainty, making the stock highly speculative with substantial downside potential. Investors should consider exiting their positions to mitigate further losses.

Keywords

DIH Holding US, DHAI, Nasdaq delisting, MVLS non-compliance, late filings, Form 10-Q, Form 10-K, rehabilitation devices, robotic rehabilitation, medical technology